Dr. Mehta is Chair of the NRG Oncology Brain Tumor Committee and previously served as a member of the FDA’s Technology Assessment Committee and chaired the FDA Radiological Devices Panel. Dr. Mehta was a member of the Board of Directors of the American Society for Therapeutic Radiology and Oncology (ASTRO).
Dr. Mehta obtained his medical degree at the University of Zambia, completed his residency in radiation oncology at UW-Madison, and chaired the UW Department of Human Oncology from 1997 to 2007. He has served in leadership positions at Northwestern University and the University of Maryland, where he was Director of the Maryland Proton Treatment Center. He has over 1000 publications.
He was a Deputy Director and Chief of Radiation Oncology of Miami Cancer Institute at Baptist Health South Florida in November of 2015 to oversee South Florida’s first and only Proton Therapy Center. Dr. Mehta is an internationally recognized expert in human clinical drug trial strategy, design, and execution, and has managed numerous national and international trials.